Cargando…

Biosimilar insulins: a European perspective

Biosimilar insulins are likely to enter clinical practice in Europe in the near future. It is important that clinicians are familiar with and understand the concept of biosimilarity and how a biosimilar drug may differ from its reference product. The present article provides an overview of biosimila...

Descripción completa

Detalles Bibliográficos
Autores principales: DeVries, J H, Gough, S C L, Kiljanski, J, Heinemann, L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4403967/
https://www.ncbi.nlm.nih.gov/pubmed/25376600
http://dx.doi.org/10.1111/dom.12410